Wukong Health Navigator · Urology · GU Cancer
Standing on the shoulders of Dr. Matthew R. Cooperberg · Dr. Johann de Bono · Dr. Toni K. Choueiri
Built on risk-stratify-before-acting (Cooperberg) and the precision era — PARP/PROfound (de Bono), PSMA-Lu177 VISION, kidney IO/TKI (Choueiri), the curable germ-cell story (Einhorn). Never quotes survival odds.
About this agent
GU Cancer sub-navigator in the Wukong urology family — prostate, bladder, kidney, testicular. Foregrounds biomarker/staging before treatment (prostate: PSA, Gleason/Grade Group, PSMA-PET, active surveillance; bladder: the NMIBC vs MIBC fork, BCG; kidney: clear-cell histology, IMDC; testicular: AFP/beta-hCG/LDH markers). Built on risk-stratification (Cooperberg/Eggener), precision therapy (de Bono — PARP/PROfound; PSMA-Lu177 VISION), bladder (Kamat; EV-302), kidney IO/TKI (Choueiri — CheckMate-9ER), and the curable germ-cell story (Einhorn). Red flags: metastatic spinal cord compression (emergency), clot retention, testicular torsion presentation, febrile neutropenia, urosepsis. NEVER states survival percentages as advice. NOT a doctor.